Navigation Links
The Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis
Date:6/11/2013

DUBLIN, June 11, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/hrlbkd/top_five_global) has announced the addition of the "Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The fragmented market has observed some changes in the competitive landscape during the last five years. The top players are expanding their footprints in the emerging markets of China, India, Brazil, Latin America, and Eastern Europe. They are strengthening their technological and R&D structure by targeted merger and acquisition activities to help develop and market innovative drugs.

This report briefly discusses the subject companies, their geographic footprints, financial metrics, market performance, marketing and corporate strategies, and provides SWOT analysis of each. The report indicates that increased regulation of the pharmaceutical industry is expected to increase the industry's cost structure and reduce revenue as getting drugs to market becomes a longer and more expensive process. Regulatory approval for the introduction of biogenerics/biosimilars, generic versions of biologic drugs, increases the threat of uncertainty to the pharmaceutical market.

This report projects the major drivers of the industry. Growth in sectors such as health awareness among populations, R&D expenditures, sales of prescribed medicine and demand for generic medicines are expect to continue to provide huge demand for medicines. Various governments' increased spending in infectious and chronic degenerative diseases as well as anti-diabetes and cardiovascular drugs has driven the growth in sales of the pharmaceutical industry.

The report gives an overview of the top five global pharmaceutical companies:

- GlaxoSmithKline Plc
- Merck & Co., Inc.
- Novartis AG
- Pfizer, Inc.
- Sanofi-Aventis


For more information visit http://www.researchandmarkets.com/research/hrlbkd/top_five_global

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Vocera Chief Medical Officer Bridget Duffy Keynotes at Top Global Health Conferences
2. Covance To Present At The Goldman Sachs 34th Annual Global Healthcare Conference
3. Bioabsorbable Stents - Global Strategic Business Report - 2013 Profiles 16 Companies inside the Market
4. Lexicon To Present At The Goldman Sachs Global Healthcare Conference
5. BD to Present at the Goldman Sachs 34th Annual Global Healthcare Conference
6. Quest Diagnostics CEO Steve Rusckowski Reaffirms Full-Year 2013 Guidance At The Jefferies 2013 Global Healthcare Conference
7. Frost & Sullivan: Standardized Regulations Crucial for Growth in Global Dimensional Metrology Market for Medical Devices
8. Global In Vitro Diagnostics Markets Outpace Pharma Industry Growth, finds Frost & Sullivan
9. Sorrento Therapeutics Receives Frost & Sullivans Prestigious 2013 Global Investment Opportunity Award in the Oncology Market
10. In Vitro Diagnostics - A Global Market Overview
11. Sorrento Therapeutics Receives Frost & Sullivans 2013 Global Investment Opportunity Award in Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... Aug. 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that its Board of Directors has approved the payment ... quarter of 2017. The ... or about October 27, 2017 to stockholders of record as ... declarations of dividends are subject to approval of the Board ...
(Date:8/7/2017)... Mich., Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), ... the quarter ended June 30, 2017.  All comparisons, unless otherwise ... Second Quarter 2017 Highlights ... to $1,089 million, an increase of 3.5% ... Gross margin of 7.5% versus 7.6% ...
(Date:8/4/2017)... 4, 2017 The search for test results ... physician/patient consult has long been the goal of healthcare ... focus of the largest meeting of lab professionals and ... market research firm Kalorama Information.  The firm said scores ... or related supplies and software were at the American ...
Breaking Medicine Technology:
(Date:8/16/2017)... , ... August 16, 2017 , ... Ten outstanding teachers ... Stars in the Classroom and will win a visit by a Houston Texans player, ... who are at least five years old can visit texanschecking.com/stars to nominate their favorite ...
(Date:8/16/2017)... ... 2017 , ... For the second year, the Brain Injury ... the public on the impact of concussions. Brooke Mills, student and founder of ... Day. , Brooke is working diligently is to raise awareness of concussion throughout ...
(Date:8/16/2017)... ... August 16, 2017 , ... QualDerm Partners , a ... today announced Cumberland Skin Surgery and Dermatology has joined the company ... in both Hermitage and Lebanon, Tennessee, provides comprehensive general dermatology and skin cancer ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... has received a three-year grant totaling $975,000, renewing its funding from the Health ... Human Services. , This funding marks, the fourth time the HRSA administration has ...
(Date:8/16/2017)... ... ... A global leader in the treatment of clubfoot, CURE International India ... the country one step closer to eliminating clubfoot as a lifelong disability by 2030. ... to enroll 10,000 children in the clubfoot treatment program in this year alone. , ...
Breaking Medicine News(10 mins):